Carolinas Centers for Sight, P.C. (CCFS) provides advanced technology procedures to North and South Carolina residents with emphasis on optimal visual outcomes. CCFS has been providing medical/surgical ophthalmology services for nearly 30 years and has five offices for patient convenience.
The Florence campus houses our clinic and ambulatory surgical facility, Florence Surgery and Laser Center. Procedures performed at FSLC include bladeless laser and bladed cataract surgery, multifocal lens implants, glaucoma and retinal surgery, eyelid and other oculoplastic surgeries. “At FSLC, patients have a surgical experience normally only available at the finest cutting edge academic teaching institutions. The reason for this is the mission of the ophthalmic surgeons at CCFS to provide the best equipment and resources available,” said Samuel E. Seltzer, MD. FSLC is accredited by the prestigious Accreditation Association for Ambulatory Health Care (AAAHC), a national leader in developing standards to promote patient safety, quality care and value for ambulatory health care.
Cataract Surgery in the 21st Century
Thanks to medical advances, cataract surgery is a common outpatient procedure. At CCFS, patients have the choice between bladed cataract surgery and the advanced technology of LenSx bladeless laser. The LenSx laser captures incredibly precise, high-resolution images of your eyes which allows our surgeons to plan and perform a procedure that is completely customized for each of your eyes.
The LenSx laser for cataract surgery has exacting, reproducible steps which provide better lens positioning, less trauma to the eye and less inflammation because the LenSx laser is less invasive and yields more predictable post-op visual results. For patients with astigmatism and for those who wish to reduce or eliminate their need for glasses, LenSx bladeless cataract surgery offers distinct advantages over bladed cataract surgery.
“ORA VerifEye+ Technology, one of the newest and most important advances in cataract surgery, provides a quantum leap in refining cataract surgery outcomes, especially in patients with preoperative astigmatism,” states Vivek P. Vasuki, MD. ORA is used in bladeless laser or bladed cataract surgery to provide real-time, continuous information that allows CCFS surgeons to validate and refine surgical plans in the operating room with data not available in pre-op analysis. This step is critical to maximizing a successful surgical outcome, since pre-op measurements are taken through the cloudy cataract. The ORA step is performed after the cataract is removed and before the new lens is inserted in the eye. ORA helps to finalize lens choice and placement of the intraocular lens implant as well as provide better outcomes for patients with astigmatism or those who have previously had LASIK surgery. Drs. Samuel E. Seltzer, Howard N. Greene and Vivek P. Vasuki all perform bladeless laser and bladed cataract surgery at CCFS.
KAMRA Inlay – Enjoy Life Without Reading Glasses
For patients struggling with difficulty seeing up close, Carolinas Centers for Sight, P.C. now offers KAMRA Inlay, an advanced surgical procedure to treat presbyopia, a frustrating natural condition that occurs in people over 40. “Someone who is 45 may only have difficulty seeing up close when trying to read very small print. However, someone who is 55 may need to use reading glasses or bifocals many times throughout the day to read a newspaper, computer screen or text message,” according to Howard N. Greene, MD.
Presbyopia reduces the ability of the eye to focus on near objects, causing blurry reading vision. KAMRA Inlay helps restore near vision and reduce the constant frustrations of reading glasses. The KAMRA Inlay sits in the first few layers of the eye known as the cornea. Smaller and thinner than a contact lens, the KAMRA Inlay is a mini-ring with an opening in the center. By using this pinhole effect, the inlay focuses light coming into the eye. This restores near vison while maintaining distance vision without blurry zones. KAMRA Inlay is placed in the non-dominant eye only. The dominant eye remains focused at distance, achieved by LASIK surgery if necessary. The procedure typically takes about 15 minutes and is performed by Howard N. Greene, MD at CCFS. Consultations for near vision correction are complimentary.
Advances in Glaucoma Surgery
The XEN gel stent is a minimally-invasive glaucoma surgery that makes significant reductions in intraocular pressure while decreasing the need for other medications. It was developed to provide long-term pressure-lowering benefits with much less surgical trauma to the eye. It also provides less risk of sight-threatening complications that are often associated with large pressure fluctuations after glaucoma surgery.
Minimally-invasive surgical approaches are revolutionizing the treatment of glaucoma. Less surgical trauma to the eye provides for safer intervention that may be done at earlier stages of the disease and allow for faster recovery after traditional glaucoma surgery. In fact, most minimally-invasive procedures are designed to be performed on patients with mild to moderate glaucoma in the hope of controlling this relentless disease and minimizing the burden of eye drops and other medications. However, the XEN gel stent is one of the few FDA-approved minimally-invasive options that can also be beneficially performed on patients with more advanced glaucoma, providing patients with even the most severe stages of glaucoma many of the same safety and recovery benefits afforded to those with less severe disease.
The XEN gel stent is also one of the few currently available minimally-invasive treatments that can be performed as a standalone procedure, rather than having to be done at the same time as cataract surgery. Therefore, both patients with glaucoma who have already had cataract surgery or who still need cataract surgery may be eligible for this more effective but minimally-invasive option. In most cases, the XEN gel stent affords suitable patients with the opportunity to lower their eye pressure and get off many glaucoma medications. XEN gel stent surgery is performed at CCFS by Howard N. Greene, MD.